About 50 Mg Eltrombopag Tablets
Get the must-have 50 Mg Eltrombopag Tablets for managing chronic immune thrombocytopenia (ITP) or hepatitis C-associated thrombocytopenia. Lavishly decorated in a brownish-orange, round, film-coated design, each opulent tablet contains 50 mg Eltrombopag Olamine. Suitable for adults and children above 1 year, this prescription-drug boosts platelet production by stimulating thrombopoietin receptors. With a shelf life of 24 months, pick yours to ensure consistent supply. Store below 30C and protect from light. Strictly for use under medical supervision. Prescription required for purchase.
Precision Therapy for Platelet Deficiency
50 Mg Eltrombopag Tablets are specifically indicated for patients with chronic immune thrombocytopenia (ITP) and hepatitis C-related thrombocytopenia. Its primary advantage lies in its targeted action to stimulate platelet production safely and efficiently. This hematological agent is generally prescribed for individuals who have not responded adequately to other treatments. Pick this opulent option to experience advanced oral care, essential in maintaining platelet counts and reducing bleeding risks under physician guidance.
Seamless International Trade & Order Fulfillment
Our 50 Mg Eltrombopag Tablets reach global destinations thanks to streamlined logistics and prompt order completion processes. With main export markets spanning Africa, Asia, the Middle East, and more, we handle valuation, documentation, and packaging meticulously. Payment terms are flexible, including advance payments and Letters of Credit (L/C). Orders are shipped through reputable FOB ports across India, ensuring timely deliveries for our distributors, exporters, and international clients.
FAQ's of 50 Mg Eltrombopag Tablets:
Q: How should I take 50 Mg Eltrombopag Tablets for optimal effectiveness?
A: Take the tablet orally, with or without food, strictly as prescribed by your physician. Avoid consuming dairy products or antacids within 4 hours of taking the dose to ensure maximum efficacy.
Q: What is the primary benefit of using Eltrombopag Tablets?
A: Eltrombopag Tablets effectively increase platelet production in patients with chronic immune thrombocytopenia or hepatitis C, helping reduce bleeding episodes and maintain safer platelet counts.
Q: When is Eltrombopag therapy recommended for use?
A: Eltrombopag is recommended for patients with chronic ITP or hepatitis C-associated thrombocytopenia who have not responded adequately to other treatments, under strict physician supervision.
Q: Where can I find the manufacturer and expiry details?
A: All manufacturing and expiry information, as well as marketing details, are clearly mentioned on the tablet's package, along with the barcode for verification.
Q: What side effects should I be aware of during treatment?
A: Possible side effects include headache, nausea, diarrhea, and changes in liver function. Consult your physician immediately if you notice any unusual symptoms.
Q: What regulatory status do these tablets hold in India?
A: 50 Mg Eltrombopag Tablets are classified as a Schedule H prescription drug in India, requiring a valid prescription for purchase and use.